Halladin相关文献与解析，生知库 | 链接生命科学的每一步

Halladin, David K; Ortega, Fabian E; Ng, Katharine M; Footer, Matthew J; Mitić, Nenad S; Malkov, Saša N; Gopinathan, Ajay; Huang, Kerwyn Casey; Theriot, Julie A

微生物学

细胞生物学

发表日期：2021

文献求助收藏

The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial

在DUAL VII随机试验中，与基础-餐时胰岛素疗法相比，胰岛素德谷/利拉鲁肽（IDegLira）的益处在2型糖尿病患者的各个亚组中均保持一致。

期刊:Journal of diabetes science and technology

影响因子:3.7

doi:10.1177/1932296820906888

Billings, Liana K; Agner, Bue F Ross; Altuntas, Yuksel; Grøn, Randi; Halladin, Natalie; Klonoff, David C; Tentolouris, Nikolaos; Jódar, Esteban

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice

DUAL VIII 是一项旨在模拟临床实践的随机试验，结果显示，在 26 周时，与使用 100 单位/毫升的甘精胰岛素相比，使用德谷胰岛素/利拉鲁肽治疗的 2 型糖尿病患者中达到治疗目标的比例更高。

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.13957

Sesti, Giorgio; Bardtrum, Lars; Dagdelen, Selcuk; Halladin, Natalie; Haluzík, Martin; Őrsy, Petra; Rodríguez, Martin; Aroda, Vanita R

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes

胰岛素德谷/利拉鲁肽作为钠-葡萄糖协同转运蛋白2抑制剂治疗的附加疗法，疗效优于胰岛素甘精U100：一项针对血糖控制不佳的2型糖尿病患者的随机临床试验

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.13666

Philis-Tsimikas, Athena; Billings, Liana K; Busch, Robert; Portillo, Cristobal Morales; Sahay, Rakesh; Halladin, Natalie; Eggert, Sarah; Begtrup, Kamilla; Harris, Stewart

Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial

在口服降糖药控制不佳的2型糖尿病患者中，每周一次与每周两次IDegLira滴定方案的安全性和有效性：DUAL VI随机临床试验

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.12892

Harris, Stewart B; Kocsis, Győző; Prager, Rudolf; Ridge, Terry; Chandarana, Keval; Halladin, Natalie; Jabbour, Serge

Fast Mechanically Driven Daughter Cell Separation Is Widespread in Actinobacteria

快速机械驱动的子细胞分离在放线菌中广泛存在

期刊:mBio

影响因子:5.1

doi:10.1128/mBio.00952-16

Xiaoxue Zhou, David K Halladin, Julie A Theriot

TagA is a secreted protease of Vibrio cholerae that specifically cleaves mucin glycoproteins.

TagA 是霍乱弧菌分泌的一种蛋白酶，能够特异性地切割粘蛋白糖蛋白

期刊:Microbiology-Sgm

影响因子:3.5

doi:10.1099/mic.0.044529-0

Szabady Rose L, Yanta Joseph H, Halladin David K, Schofield Mark J, Welch Rodney A

免疫/内分泌

发表日期：2011

文献求助收藏

Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells

真核翻译起始因子 4F 结构改变伴随痘病毒感染细胞中的翻译起始因子重新分布

期刊:Molecular and Cellular Biology

影响因子:3.2

doi:10.1128/MCB.01631-07

Derek Walsh, Carolina Arias, Cesar Perez, David Halladin, Martin Escandon, Takeshi Ueda, Rie Watanabe-Fukunaga, Rikiro Fukunaga, Ian Mohr

Uropathogenic Escherichia coli CFT073 is adapted to acetatogenic growth but does not require acetate during murine urinary tract infection.

泌尿道致病性大肠杆菌 CFT073 适应于产乙酸生长，但在小鼠泌尿道感染期间不需要乙酸

期刊:Infection and Immunity

影响因子:2.8

doi:10.1128/IAI.00618-08

Anfora Andrew T, Halladin David K, Haugen Brian J, Welch Rodney A

Entropy-driven translocation of disordered proteins through the Gram-positive bacterial cell wall

熵驱动的无序蛋白穿过革兰氏阳性细菌细胞壁的转运

The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial

在DUAL VII随机试验中，与基础-餐时胰岛素疗法相比，胰岛素德谷/利拉鲁肽（IDegLira）的益处在2型糖尿病患者的各个亚组中均保持一致。

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice

DUAL VIII 是一项旨在模拟临床实践的随机试验，结果显示，在 26 周时，与使用 100 单位/毫升的甘精胰岛素相比，使用德谷胰岛素/利拉鲁肽治疗的 2 型糖尿病患者中达到治疗目标的比例更高。

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes

胰岛素德谷/利拉鲁肽作为钠-葡萄糖协同转运蛋白2抑制剂治疗的附加疗法，疗效优于胰岛素甘精U100：一项针对血糖控制不佳的2型糖尿病患者的随机临床试验

Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial

在口服降糖药控制不佳的2型糖尿病患者中，每周一次与每周两次IDegLira滴定方案的安全性和有效性：DUAL VI随机临床试验

Fast Mechanically Driven Daughter Cell Separation Is Widespread in Actinobacteria

快速机械驱动的子细胞分离在放线菌中广泛存在

TagA is a secreted protease of Vibrio cholerae that specifically cleaves mucin glycoproteins.

TagA 是霍乱弧菌分泌的一种蛋白酶，能够特异性地切割粘蛋白糖蛋白

Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells

真核翻译起始因子 4F 结构改变伴随痘病毒感染细胞中的翻译起始因子重新分布

Uropathogenic Escherichia coli CFT073 is adapted to acetatogenic growth but does not require acetate during murine urinary tract infection.

泌尿道致病性大肠杆菌 CFT073 适应于产乙酸生长，但在小鼠泌尿道感染期间不需要乙酸